Cargando…
Barnase as a New Therapeutic Agent Triggering Apoptosis in Human Cancer Cells
BACKGROUND: RNases are currently studied as non-mutagenic alternatives to the harmful DNA-damaging anticancer drugs commonly used in clinical practice. Many mammalian RNases are not potent toxins due to the strong inhibition by ribonuclease inhibitor (RI) presented in the cytoplasm of mammalian cell...
Autores principales: | Edelweiss, Evelina, Balandin, Taras G., Ivanova, Julia L., Lutsenko, Gennady V., Leonova, Olga G., Popenko, Vladimir I., Sapozhnikov, Alexander M., Deyev, Sergey M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413406/ https://www.ncbi.nlm.nih.gov/pubmed/18560598 http://dx.doi.org/10.1371/journal.pone.0002434 |
Ejemplares similares
-
Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology
por: Shilova, Olga, et al.
Publicado: (2021) -
CID fragmentation, H/D exchange and supermetallization of Barnase-Barstar complex
por: Kostyukevich, Yury, et al.
Publicado: (2017) -
A Novel Approach to Anticancer Therapy: Molecular Modules Based on the Barnase:Barstar Pair for Targeted Delivery of HSP70 to Tumor Cells
por: Sapozhnikov, A. M., et al.
Publicado: (2018) -
Why the Energy Landscape of Barnase Is Hierarchical
por: Pandya, Maya J., et al.
Publicado: (2018) -
Barnase-barstar Specific Interaction Regulates Car-T Cells Cytotoxic Activity toward Malignancy
por: Kalinin, R. S., et al.
Publicado: (2023)